tiprankstipranks
Advertisement
Advertisement

Shanghai INT Medical Instruments Sets Board Meeting to Approve 2025 Results and Consider Dividend

Story Highlights
  • Shanghai INT Medical Instruments, a Hong Kong-listed Chinese medical device maker, operates with a diversified board led by Chairman Dr. Liang Dongke.
  • The board will meet on 27 March 2026 to approve 2025 annual results and consider a potential final dividend for shareholders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Shanghai INT Medical Instruments Sets Board Meeting to Approve 2025 Results and Consider Dividend

Meet Samuel – Your Personal Investing Prophet

Shanghai Kindly Medical Instruments Co., Ltd. Class H ( (HK:1501) ) has provided an announcement.

Shanghai INT Medical Instruments Co., Ltd., a Hong Kong-listed Chinese medical device manufacturer, announced that its board includes a mix of executive, non-executive and independent non-executive directors led by Chairman Dr. Liang Dongke. The company operates in the medical instruments sector, supplying products to healthcare markets.

The board will meet on 27 March 2026 to review and approve the audited annual results for the year ended 31 December 2025 and decide on the possible payment of a final dividend. The meeting outcome will determine the company’s profit distribution to shareholders and provide investors with an official view of its financial performance for 2025.

The most recent analyst rating on (HK:1501) stock is a Buy with a HK$35.00 price target. To see the full list of analyst forecasts on Shanghai Kindly Medical Instruments Co., Ltd. Class H stock, see the HK:1501 Stock Forecast page.

More about Shanghai Kindly Medical Instruments Co., Ltd. Class H

Shanghai INT Medical Instruments Co., Ltd. is a PRC-incorporated medical device company listed in Hong Kong, operating through a board comprising executive, non-executive and independent non-executive directors. The company focuses on designing, manufacturing and selling medical instruments, serving healthcare providers in domestic and potentially international markets.

Average Trading Volume: 182,326

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$6.36B

See more data about 1501 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1